SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-16-025117
Filing Date
2016-09-12
Accepted
2016-09-12 16:08:15
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 fate-s3_20160912.htm S-3 300358
2 EX-5.1 fate-ex51_6.htm EX-5 6721
3 EX-23.1 fate-ex231_7.htm EX-23 2269
4 GRAPHIC g54obpi4b430000001.jpg GRAPHIC 2812
5 GRAPHIC gljdbneynvnq000001.jpg GRAPHIC 2630
6 GRAPHIC gljdbneynvnq000002.jpg GRAPHIC 2630
  Complete submission text file 0001564590-16-025117.txt   321931
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: S-3 | Act: 33 | File No.: 333-213590 | Film No.: 161881091
SIC: 2836 Biological Products, (No Diagnostic Substances)